Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Operating Expenses (2022 - 2025)

Historic Operating Expenses for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $8.4 million.

  • CervoMed's Operating Expenses rose 1405.04% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year increase of 4177.34%. This contributed to the annual value of $28.0 million for FY2024, which is 8696.04% up from last year.
  • As of Q3 2025, CervoMed's Operating Expenses stood at $8.4 million, which was up 1405.04% from $8.4 million recorded in Q2 2025.
  • CervoMed's 5-year Operating Expenses high stood at $9.4 million for Q4 2024, and its period low was $904054.0 during Q3 2022.
  • Over the past 4 years, CervoMed's median Operating Expenses value was $5.0 million (recorded in 2023), while the average stood at $5.3 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 42949.58% in 2023, then surged by 1405.04% in 2025.
  • Quarter analysis of 4 years shows CervoMed's Operating Expenses stood at $938823.0 in 2022, then soared by 429.5% to $5.0 million in 2023, then surged by 89.15% to $9.4 million in 2024, then dropped by 11.02% to $8.4 million in 2025.
  • Its Operating Expenses stands at $8.4 million for Q3 2025, versus $8.4 million for Q2 2025 and $7.2 million for Q1 2025.